<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="136325">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02109380</url>
  </required_header>
  <id_info>
    <org_study_id>METC 14-3-013</org_study_id>
    <nct_id>NCT02109380</nct_id>
  </id_info>
  <brief_title>Bed-rest, Muscle Mass and Insulin Sensitivity</brief_title>
  <official_title>The Impact of Short-term Bed-rest on Skeletal Muscle Mass and Insulin Sensitivity in Healthy, Young Men</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <authority>Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the present study, the effects of 7 days of bed rest on muscle mass, muscle fiber
      characteristics and insulin sensitivity will be determined.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Change in quadriceps muscle cross-sectional area</measure>
    <time_frame>One day before and directly after cessation of bed rest.</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in lower back cross-sectional area</measure>
    <time_frame>One day before and directly after cessation of bed rest.</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in leg and whole body lean tissue mass</measure>
    <time_frame>One day before and directly after cessation of bed rest.</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in muscle fiber size</measure>
    <time_frame>One day before and directly after cessation of bed rest.</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in muscle strength</measure>
    <time_frame>One day before and directly after cessation of bed rest.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measured by 1-Repetition Maximum testing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in insulin sensitivity</measure>
    <time_frame>One day before and directly after cessation of bed rest.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measured by hyperinsulinemic-euglycemic clamp</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Disuse Atrophy</condition>
  <arm_group>
    <arm_group_label>Bed rest</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One week of bed rest.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Bed rest</intervention_name>
    <arm_group_label>Bed rest</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male

          -  Aged from 18-35 years

          -  18.5 &lt; BMI &lt; 30 kg/m2

        Exclusion Criteria:

          -  Smoking

          -  Performing regular resistance training (3+ times per week, carrying out progressive
             training) in the previous 6 months

          -  Hypertension (according to WHO criteria) and/or cardiovascular disease

          -  Any back/leg/knee/neck/postural complaints

          -  Use of any prescribed medication

          -  Type 2 diabetes mellitus

          -  Any family history of thrombosis

          -  All co-morbidities interacting with mobility and muscle metabolism of the lower limbs
             (e.g. arthritis, spasticity/rigidity, all neurological disorders and paralysis).

          -  Myocardial infarction within the last 3 years

          -  Use of anti-coagulants
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luc JC van Loon, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht UMC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marlou Dirks, MSc</last_name>
    <phone>+31-433882215</phone>
    <email>marlou.dirks@maastrichtuniversity.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Maastricht University Medical Centre</name>
      <address>
        <city>Maastricht</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Luc JC van Loon, PhD</last_name>
      <phone>+31-43-3881397</phone>
      <email>l.vanloon@maastrichtuniversity.nl</email>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 4, 2014</lastchanged_date>
  <firstreceived_date>April 1, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Maastricht University Medical Center</investigator_affiliation>
    <investigator_full_name>Lex Verdijk</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Muscular Disorders, Atrophic</mesh_term>
    <mesh_term>Atrophy</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
